G. Tuysuz Et Al. , "THE INCIDENCE OF THE SENSORINEURAL HEARING LOSS AND OCULAR TOXICITY IN beta-THALASSEMIA PATIENTS RECEIVING DESFERRIOXAMINE CHELATION THERAPY," HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , vol.95, pp.721, 2010
Tuysuz, G. Et Al. 2010. THE INCIDENCE OF THE SENSORINEURAL HEARING LOSS AND OCULAR TOXICITY IN beta-THALASSEMIA PATIENTS RECEIVING DESFERRIOXAMINE CHELATION THERAPY. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , vol.95 , 721.
Tuysuz, G., Aydogan, G., Eltutar, K., Yigit, O. E., Uzunlulu, O. E., Gor, P., ... Akcay, A.(2010). THE INCIDENCE OF THE SENSORINEURAL HEARING LOSS AND OCULAR TOXICITY IN beta-THALASSEMIA PATIENTS RECEIVING DESFERRIOXAMINE CHELATION THERAPY. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , vol.95, 721.
Tuysuz, G. Et Al. "THE INCIDENCE OF THE SENSORINEURAL HEARING LOSS AND OCULAR TOXICITY IN beta-THALASSEMIA PATIENTS RECEIVING DESFERRIOXAMINE CHELATION THERAPY," HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , vol.95, 721, 2010
Tuysuz, G. Et Al. "THE INCIDENCE OF THE SENSORINEURAL HEARING LOSS AND OCULAR TOXICITY IN beta-THALASSEMIA PATIENTS RECEIVING DESFERRIOXAMINE CHELATION THERAPY." HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , vol.95, pp.721, 2010
Tuysuz, G. Et Al. (2010) . "THE INCIDENCE OF THE SENSORINEURAL HEARING LOSS AND OCULAR TOXICITY IN beta-THALASSEMIA PATIENTS RECEIVING DESFERRIOXAMINE CHELATION THERAPY." HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , vol.95, p.721.
@article{article, author={G. Tuysuz Et Al. }, title={THE INCIDENCE OF THE SENSORINEURAL HEARING LOSS AND OCULAR TOXICITY IN beta-THALASSEMIA PATIENTS RECEIVING DESFERRIOXAMINE CHELATION THERAPY}, journal={HAEMATOLOGICA-THE HEMATOLOGY JOURNAL}, year=2010, pages={721} }